Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being combined with chemotherapy and targeted therapy for lung cancer treatment at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being combined with chemotherapy and targeted therapy for lung cancer treatment at the 2017 Annual Meeting Annual Meeting in Chicago, IL.